Remove Certification Remove Hospital Remove Thrombolysis
article thumbnail

Associations Between Measures of Structural Racism and Receipt of Acute Ischemic Stroke Interventions in the United States

Journal of the American Heart Association

We explored the interplay among structural racism, urbanity, and intravenous thrombolysis (tissue plasminogen activator) and endovascular thrombectomy (ET).Methods Among 951 914 patients, rural hospitals demonstrated lower intensive care unit capacity (27.5% versus 88.6%), stroke certification (5.3% versus 0.11

Stroke 45
article thumbnail

Performance of Thrombectomy-Capable, Comprehensive, and Primary Stroke Centers in Reperfusion Therapies for Acute Ischemic Stroke: Report From the Get With The Guidelines–Stroke Registry

Circulation

BACKGROUND:The thrombectomy-capable stroke center (TSC) is a recently introduced intermediate tier of accreditation for hospitals at which patients with acute ischemic stroke receive care. 1.31]), whereas the odds of in-hospital mortality or discharge to hospice were lower in both CSCs compared with PSCs (OR, 0.87 [95% CI, 0.81–0.94])

Stroke 40
article thumbnail

Abstract WMP28: Developing a New Hospital Into a Primary Stroke Center in Just Over a Year

Stroke Journal

There is little data on certified stroke programs being established in new hospitals. In this study we compared data from the opening of a 160-bed hospital until achieving Primary Stroke Center (PSC) certification (October 2021 - February 2023) to after certification (March 2023 - June 2023).

article thumbnail

Abstract WP152: Associations between measures of structural racism and receipt of acute ischemic stroke interventions in the US

Stroke Journal

This study explores the interaction between structural racism, urbanity, and the administration of acute ischemic stroke (AIS) interventionsspecifically, intravenous thrombolysis (TPA) and endovascular thrombectomy (ET).Methods:This vs. 88.6%), stroke certification (5.3% vs. 38.4%), and lower rates of TPA (1.6% for TPA, 1.27

Stroke 40
article thumbnail

The “open data” movement runs aground on FOURIER

Dr. Anish Koka

The TIMI (Thrombolysis in Myocardial Infarction) Study Group is a Division of Cardiovascular Medicine at the esteemed Brigham and Women’s Hospital and Harvard Medical School. Trials of this size are complex and can’t be done by just anyone, which is why the famed TIMI group was tasked with the job.